| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 136 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2019 | Collier Alan Brian | CEO | Buy | 17,000 | $0.02 | $389.00 | - | |
| Feb 15, 2019 | Collier Alan Brian | CEO | Buy | 174,000 | $0.02 | $3,931.60 | - | |
| Feb 12, 2019 | Collier Alan Brian | CEO | Buy | 213,000 | $0.02 | $4,806.50 | - | |
| Feb 12, 2019 | Collier Alan Brian | CEO | Buy | 17,500 | $0.02 | $390.25 | - | |
| Feb 7, 2019 | Collier Alan Brian | CEO | Buy | 38,000 | $0.03 | $984.80 | - | |
| Feb 4, 2019 | Mann Michael Scott | President | Buy | 4,000 | $0.03 | $103.20 | - | |
| Jan 31, 2019 | Collier Alan Brian | CEO | Buy | 46,000 | $0.03 | $1,188.30 | - | |
| Jan 29, 2019 | Collier Alan Brian | CEO | Buy | 59,000 | $0.03 | $1,696.40 | - | |
| Jan 25, 2019 | Collier Alan Brian | CEO | Buy | 120,500 | $0.03 | $3,305.95 | - | |
| Jan 22, 2019 | Collier Alan Brian | CEO | Buy | 65,500 | $0.03 | $1,773.95 | - |